A multicentre, retrospective study analysing clinical practice experience with HyQvia in Adults Using Alternative Dosing Regimens and Pediatric Patients
Latest Information Update: 06 Mar 2020
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Adverse reactions
Most Recent Events
- 06 Mar 2020 New trial record
- 02 Mar 2020 Results assessing requiring alternative rates, ramp-up, and/or dosing regimens in adults and children, published in the Advances in Therapy